99 related articles for article (PubMed ID: 25940384)
1. Dissecting genetic and environmental mutation signatures with model organisms.
Segovia R; Tam AS; Stirling PC
Trends Genet; 2015 Aug; 31(8):465-74. PubMed ID: 25940384
[TBL] [Abstract][Full Text] [Related]
2. Mutational signatures and mutable motifs in cancer genomes.
Rogozin IB; Pavlov YI; Goncearenco A; De S; Lada AG; Poliakov E; Panchenko AR; Cooper DN
Brief Bioinform; 2018 Nov; 19(6):1085-1101. PubMed ID: 28498882
[TBL] [Abstract][Full Text] [Related]
3. decompTumor2Sig: identification of mutational signatures active in individual tumors.
Krüger S; Piro RM
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
[TBL] [Abstract][Full Text] [Related]
4. Chemically induced mutations in a MutaMouse reporter gene inform mechanisms underlying human cancer mutational signatures.
Beal MA; Meier MJ; LeBlanc DP; Maurice C; O'Brien JM; Yauk CL; Marchetti F
Commun Biol; 2020 Aug; 3(1):438. PubMed ID: 32796912
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
Islam SMA; Alexandrov LB
Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
7. Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer.
Fox EJ; Salk JJ; Loeb LA
Genome Med; 2016 Mar; 8(1):30. PubMed ID: 26987311
[TBL] [Abstract][Full Text] [Related]
8. signeR: an empirical Bayesian approach to mutational signature discovery.
Rosales RA; Drummond RD; Valieris R; Dias-Neto E; da Silva IT
Bioinformatics; 2017 Jan; 33(1):8-16. PubMed ID: 27591080
[TBL] [Abstract][Full Text] [Related]
9. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
Shiraishi Y; Tremmel G; Miyano S; Stephens M
PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
11. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes.
Alexandrov LB; Stratton MR
Curr Opin Genet Dev; 2014 Feb; 24(100):52-60. PubMed ID: 24657537
[TBL] [Abstract][Full Text] [Related]
12. Helmsman: fast and efficient mutation signature analysis for massive sequencing datasets.
Carlson J; Li JZ; Zöllner S
BMC Genomics; 2018 Nov; 19(1):845. PubMed ID: 30486787
[TBL] [Abstract][Full Text] [Related]
13. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
[TBL] [Abstract][Full Text] [Related]
14. Understanding mutagenesis through delineation of mutational signatures in human cancer.
Petljak M; Alexandrov LB
Carcinogenesis; 2016 Jun; 37(6):531-40. PubMed ID: 27207657
[TBL] [Abstract][Full Text] [Related]
15. Modelling Mutation Spectra of Human Carcinogens Using Experimental Systems.
Zhivagui M; Korenjak M; Zavadil J
Basic Clin Pharmacol Toxicol; 2017 Sep; 121 Suppl 3():16-22. PubMed ID: 27754614
[TBL] [Abstract][Full Text] [Related]
16. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
17. Application of second-generation sequencing to cancer genomics.
Robison K
Brief Bioinform; 2010 Sep; 11(5):524-34. PubMed ID: 20427421
[TBL] [Abstract][Full Text] [Related]
18. Understanding genomic alterations in cancer genomes using an integrative network approach.
Wang E
Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
[TBL] [Abstract][Full Text] [Related]
19. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
20. Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution.
Ivanov D; Hwang T; Sitko LK; Lee S; Gartner A
Biochem Soc Trans; 2023 Jun; 51(3):1307-1317. PubMed ID: 37283472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
